open access

Vol 70, No 3 (2020)
Guidelines and recommendations
Get Citation

Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours

Tomasz Jastrzębski, Piotr Richter, Wojciech Zegarski, Adam Dziki, Grzegorz Wallner, Arkadiusz Jeziorski, Wojciech M. Wysocki, Marek Jackowski, Marek Bębenek, Tomasz Olesiński, Wojciech Polkowski, Lucjan Wyrwicz, Dariusz Wydra, Wojciech Biernat, Piotr Czauderna, Michał Studniarek, Tomasz Polec, Radosław Owczuk, Anna Sommer, Krzysztof Szewczyk, Jerzy Mielko
DOI: 10.5603/NJO.2020.0019
·
Nowotwory. Journal of Oncology 2020;70(3):85-91.

open access

Vol 70, No 3 (2020)
Guidelines and recommendations

Abstract

Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%. The conditions necessary for positive results of such treatment include the high experience of a given centre, its appropriate infrastructure, and appropriate patient qualification for the procedure. As a result of the debate connected with the need to evaluate treatment quality and results, at the request of the Peritoneal Cancer Section of the Polish Society of Oncological Surgery, the conditions for quality assurance were worked out and a Quality Assurance Commission was set up for the centres performing cytoreductive procedures and HIPEC procedures in the treatment of primary and secondary peritoneal tumours.

Abstract

Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%. The conditions necessary for positive results of such treatment include the high experience of a given centre, its appropriate infrastructure, and appropriate patient qualification for the procedure. As a result of the debate connected with the need to evaluate treatment quality and results, at the request of the Peritoneal Cancer Section of the Polish Society of Oncological Surgery, the conditions for quality assurance were worked out and a Quality Assurance Commission was set up for the centres performing cytoreductive procedures and HIPEC procedures in the treatment of primary and secondary peritoneal tumours.

Get Citation

Keywords

quality assurance; cytoreduction; HIPEC; treatment quality; peritoneal cancers

About this article
Title

Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours

Journal

Nowotwory. Journal of Oncology

Issue

Vol 70, No 3 (2020)

Pages

85-91

DOI

10.5603/NJO.2020.0019

Bibliographic record

Nowotwory. Journal of Oncology 2020;70(3):85-91.

Keywords

quality assurance
cytoreduction
HIPEC
treatment quality
peritoneal cancers

Authors

Tomasz Jastrzębski
Piotr Richter
Wojciech Zegarski
Adam Dziki
Grzegorz Wallner
Arkadiusz Jeziorski
Wojciech M. Wysocki
Marek Jackowski
Marek Bębenek
Tomasz Olesiński
Wojciech Polkowski
Lucjan Wyrwicz
Dariusz Wydra
Wojciech Biernat
Piotr Czauderna
Michał Studniarek
Tomasz Polec
Radosław Owczuk
Anna Sommer
Krzysztof Szewczyk
Jerzy Mielko

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl